Virginia Catalyst Announces COVID-19 Grant Funding

RICHMOND, VA – January 28, 2021  – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is conducting a formalized, competitive, one-time COVID-19 Therapeutic Drug Grant Funding Round of up to $5,000,000 to:

• Support the acceleration of clinical testing by one or more Virginia companies of a therapeutic drug that treats life-threatening symptoms caused by COVID-19
• Encourage collaborative partnerships between investigators at one or more Virginia research universities and each grant recipient
• Increase Virginia’s national and global competitiveness in the life sciences by creating critical mass through collaborations between and among Virginia’s research universities and industry partners
• Create investment or jobs in Virginia

The Catalyst is now accepting applications for this special COVID-19 Grant Round.

Learn more about the: Funding Criteria for COVID-19 Grant Round
Read the full press release